跳转至内容
Merck
CN

N3910

中和液 B

别名:

DNA neutralization solution, neutralization buffer DNA extraction

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

NACRES:
NA.25
UNSPSC Code:
12161703
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


grade

Molecular Biology

Quality Level

form

liquid

feature

Direct PCR

technique(s)

DNA amplification: suitable, DNA extraction: suitable, PCR: suitable

input

crude DNA

storage temp.

−20°C

General description

这种中和缓冲液B要与 Sigma′REDExtract-N-Amp 组织 PCR.试剂盒一起使用。该缓冲液用于中和DNA提取液,并与REDExtract-N-Amp PCR 反应混合液及PCR引物一起用于扩增靶标DNA。 REDExtract-N-Amp试剂盒包括足够体积的中和缓冲液B,每次提取至少可中和一次。 不过,如果需要更多的扩增反应,则可能需要补充额外的中和缓冲液。

Application

中和缓冲液B 已用于改良 Sigma Extract-N-Amp提取程序。它还用于小鼠的基因分型,在聚合酶链反应 (PCR) 之前可使用Sigma的REDExtract-N-Amp PCR 反应混合物来中和DNA提取液。

Legal Information

Extract-N-Amp is a trademark of Sigma-Aldrich Co. LLC
REDExtract-N-Amp is a trademark of Sigma-Aldrich Co. LLC


pictograms

Exclamation markEnvironment

signalword

Warning

Hazard Classifications

Aquatic Chronic 2 - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1

存储类别

12 - Non Combustible Liquids

法规信息

低风险生物材料

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


实验方案

SYBR® Green Extract-N-Amp™ Tissue PCR Kit enables rapid genomic DNA extraction and amplification from animal tissues.


A high-throughput functional genomics workflow based on CRISPR/Cas9-mediated targeted mutagenesis in zebrafish
Varshney GK, et al.
Nature Protocols, 11(12), 2357-2357 (2016)
Jun He et al.
Pharmacology, biochemistry, and behavior, 86(2), 327-333 (2006-12-16)
Adolescence is an important stage of brain development. Recent studies have indicated that neurogenesis in the brain occurs throughout life prompting comparisons of adolescent and adult neurogenesis. Since insulin-like growth factor 1 (IGF-1) has been implicated in promoting neurogenesis we
Zhiwei Wang et al.
PloS one, 6(6), e20537-e20537 (2011-06-16)
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related death in the United States, suggesting that novel strategies for the prevention and treatment of PDAC are urgently needed. K-ras mutations are observed in >90% of pancreatic cancer, suggesting



全球贸易项目编号

货号GTIN
N3910-2.5ML04061837301117
N3910-240ML04061837301131
N3910-6ML04061837301186
N3910-1.2ML04061837301094
N3910-24ML04061834116387
N3910-60ML04061837301162